Skip to Content

Investor Relations

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent...
Read More

Corporate Profile

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent home and alternate site infusion services provider in the United States. With over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary Option Care Health to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call
BANNOCKBURN, Ill., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that the Company will release results for its fourth quarter
Toggle Summary Option Care Health Completes Reverse Stock Split and Ticker Symbol Change
BANNOCKBURN, Ill. , Feb. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that it has completed the reverse 1-for-4 stock split of its
Toggle Summary Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference
BANNOCKBURN, Ill. , Dec. 18, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate site infusion therapy services, will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 . John C.